The care for chronic disease management addresses pain points at scale and has the potential to become a large business globally.
Akshay Datt speaks with Jogin Desai, Founder & CEO of Eyestem, a leading cell therapy company in India that aims to set a new benchmark for quality and affordability in this domain.
Dr. Desai has previously served as the CEO of Cenduit and has extensive experience in growing and nurturing businesses. He founded Eyestem in 2016 to develop cell therapy in order to address Age-related Macular Degeneration (AMD), an eye disease that causes vision loss.
Tune in to this episode to hear Dr Desai speak about how Eyestem plans to pioneer the development of the cell therapy industry.
- Developing the product.
- Targeting incurable diseases.
- Commercializing Eyestem.